Immunic Q3 EPS $(0.99) Misses $(0.96) Estimate

Benzinga · 1d ago
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.96) by 3.13 percent. This is a 25 percent increase over losses of $(1.32) per share from the same period last year.